Dr. Hunter has experience in biotechnology and nanotechnology patent analysis and prosecution, strategic portfolio management, and infringement, enforcement and due diligence analyses and opinions. He has extensive experience preparing and prosecuting patent applications in the areas of molecular biology, physiology, immunology, stem cell therapeutics, oncology, neurobiology, protein engineering, functional genomics, diagnostics, and therapeutics, as well as “hybrid areas” including biomaterials, bioengineering, molecular machines, biological computers, and molecular memories.

Prior to joining WAVS IP, Dr. Hunter worked for the Quine Intellectual Property Law Group, P.C. as Of Counsel. Previously Dr. Hunter was a partner at Skjerven Morrill MacPherson, LLP, and before that practiced as an associate attorney at Townsend and Townsend and Crew, LLP and at Majestic, Parsons, Siebert and Hsue, LLP. Dr. Hunter was also staff scientist with American Science and Engineering and with Harvard Cyclotron Laboratory before attending graduate school. After he completed the Ph.D. program at University of California at Berkeley, Dr. Hunter joined Operon Technologies as a Senior Scientist helping Operon grow from three employees to a company valued at more than $100 million.

Hosted by the Office of Intellectual Property & Industry Sponsored Research